Dare Bioscience Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.78

+0.04 (+4.88%)

As of Sep 20, 10:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +425.3% upside

Low Target $2.96

Average Target $4.12

High Target $5.49

Current Price $0.78

Current
$0.78

Target
$4.12

$2.96 $4.12 avg $5.49

Scenario Analysis

Bear Case

$2.96

277.4%

Low target

Base Case

$4.12

+425.3%

Avg target

Bull Case

$5.49

+600.0%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$3.78

-79.3% from high

52-Week Low

$0.69

+13.7% from low

Target vs 52W High

$4.12

+9.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%